Bimatoprost is contraindicated in patients with a past medical history of bimatoprost hypersensitivity or hypersensitivity to ingredients within the formulation. These include preservatives such as benzalkonium chloride.

Use of bimatoprost may not be appropriate for some cases of closed-angle glaucoma and inflammatory or neovascular glaucoma.

Contact lenses should be removed before application of bimatoprost ophthalmic solution. Contact lenses can be reinserted after 15 minutes.

Intraocular application of bimatoprost ophthalmic solution for glaucoma is contraindicated in neonates, infants, and children due to concern for pigmentation changes after long-term use.

Safety and efficacy of bimatoprost ophthalmic 0.03% dermal application for hypotrichosis have not been studied in children, neonates, and infants younger than five years old. The application should only be considered if the potential benefits justify the potential calculated risks.

The use of bimatoprost ophthalmic solution has not been adequately studied in pregnant women.